Atorvastatin-10mg-10s-blister (Atorvastatin 10mg 10s Blister)
This text is not readable.*
Atorvastatin Calcium
Product Images NDC 67296-2055
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 67296-2055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Atorvastatin-10mg-10s-cart-1 (Atorvastatin 10mg 10s Cart 1)
Atorvastatin-10mg-90s-tab-1 (Atorvastatin 10mg 90s Tab 1)
This is a description for Atorvastatin Calcium tablets, each film-coated tablet containing 10 mg of Atorvastatin Calcium. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) in a dry, unvarnished area. The tablets should be dispensed in tight containers. The usual dosage information can be found in the package insert. It is essential to keep Atorvastatin Calcium Tablets and all medications out of reach of children. These tablets are manufactured by Alkem Laboratories Ltd. in India and distributed by Ascend Laboratories, LLC in Parsippany, New Jersey. For patient information, please refer to the specified website.*
Atorvastatin-20mg-500s-tab-1 (Atorvastatin 20mg 500s Tab 1)
This text provides information about Atorvastatin Calcium Tablets containing 20 mg of Atorvastatin, with details on storage conditions, dosage, and safety precautions. The tablets are to be stored at controlled room temperature, dispensed in tight containers, and kept out of children's reach. The manufacturer is Alkem Laboratories Ltd. in India, and they are distributed by Ascend Laboratories, LLC in Parsippany, NJ. For detailed prescribing information and patient resources, visit the website provided.*
Atorvastatin-40mg-1000s-tab-1. (Atorvastatin 40mg 1000s Tab 1)
This text provides information about Atorvastatin Calcium tablets, with each film-coated tablet containing 40 mg of Atorvastatin. The tablets should be stored at a controlled room temperature of 20° to 25°C (68° to 77°F). The packaging information includes the NDC number, dosage information, storage instructions, and manufacturer details. The tablets should be dispensed in tight containers and kept out of the reach of children. For complete prescribing information, refer to the package insert. Additional details can be found by visiting the website mentioned.*
Atorvastatin-80mg-1000s-tab-1 (Atorvastatin 80mg 1000s Tab 1)
This text provides information about Atorvastatin Calcium tablets containing 80 mg of Atorvastatin. The tablets should be stored at controlled room temperature. It advises to keep them out of reach of children and provides a website link for patient information. The manufacturer is Alkem Laboratories Ltd. from India, and they are distributed by Ascend Laboratories, LLC in Parsippany, NJ. The package contains 1000 tablets, and the NDC number is 67877-514-10.*
Atorvastatin-fig-1 (Atorvastatin Fig 1)
This text provides information on cumulative incidence (%) for Atorastatin and Placebo over a period of 20 to 35 years. The hazard ratio (HR), confidence interval, and p-value are also included in the data.*
Atorvastatin-fig-2 (Atorvastatin Fig 2)
This is a comparison of the effect of placebo versus atorvastatin on the cumulative hazard over time. The hazard ratio (HR) for atorvastatin compared to placebo is 0.63 with a 95% confidence interval of 0.48 to 0.83, indicating a significant effect in favor of atorvastatin (p=0.001). The graph displays the cumulative hazard percentage over the first four years of follow-up.*
Atorvastatin-fig-3 (Atorvastatin Fig 3)
This excerpt provides data on the percentage of subjects experiencing an event in relation to Atorvastatin at different dosages. The results show a hazard ratio of 0.78 with confidence interval (0.69-0.89), indicating a potentially lower risk associated with Atorvastatin. The study also mentions the time to the first major cardiovascular endpoint in years.*
Atorvastatin-st (Atorvastatin St)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
